Antiproliferative Activity of Mycalin A and Its Analogues on Human Skin Melanoma and Human Cervical Cancer Cells.
Domenica CapassoNicola BorboneMonica TerraccianoSonia Di GaetanoVincenzo PiccialliPublished in: Marine drugs (2020)
Mycalin A, a polybrominated C15 acetogenin isolated from the encrusting sponge Mycale rotalis, displays an antiproliferative activity on human melanoma (A375) and cervical adenocarcinoma (HeLa) cells and induces cell death by an apoptotic mechanism. Various analogues and degraded derivatives of the natural substance have been prepared. A modification of the left-hand part of the molecule generates the most active substances. A structurally simplified lactone derivative of mycalin A, lacking the C1-C3 side chain, is the most active among the synthesized compounds exhibiting a strong cytotoxicity on both A375 and HeLa cells but not but not on human dermal fibroblast (HDF) used as healthy cells. Further evidence on a recently discovered chlorochromateperiodate-catalyzed process, used to oxidise mycalin A, have been collected.
Keyphrases
- cell cycle arrest
- cell death
- induced apoptosis
- endothelial cells
- induced pluripotent stem cells
- pi k akt
- squamous cell carcinoma
- pluripotent stem cells
- endoplasmic reticulum stress
- signaling pathway
- drinking water
- oxidative stress
- molecular docking
- molecular dynamics simulations
- locally advanced
- rectal cancer
- skin cancer